---
title: "12 Health Care Stocks Moving In Friday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295933199.md"
description: "In Friday's pre-market session, several healthcare stocks moved significantly. Gainers included Capricor Therapeutics (+94.8%), Akanda (+57.3%), and China SXT Pharmaceuticals (+32.5%), with many citing Q2 earnings reports. Losers featured BeyondSpring (-19.6%), Healthcare Triangle (-18.5%), and Zentalis Pharmaceuticals (-15.7%)."
datetime: "2026-08-14T12:06:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295933199.md)
  - [en](https://longbridge.com/en/news/295933199.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295933199.md)
---

# 12 Health Care Stocks Moving In Friday's Pre-Market Session

### Gainers

-   **Capricor Therapeutics** (NASDAQ:CAPR) stock rose 94.8% to $8.2 during Friday's pre-market session. The company's market cap stands at $243.8 million. As per the news, the Q2 earnings report came out yesterday.
-   **Akanda** (NASDAQ:AKAN) shares rose 57.27% to $7.88. The market value of their outstanding shares is at $2.7 million.
-   **China SXT Pharmaceuticals** (NASDAQ:SXTC) stock increased by 32.5% to $4.37. The market value of their outstanding shares is at $1.7 million.
-   **Valneva** (NASDAQ:VALN) stock rose 28.14% to $7.24. The market value of their outstanding shares is at $576.9 million. The company's, Q2 earnings came out yesterday.
-   **HeartFlow** (NASDAQ:HTFL) stock increased by 25.77% to $39.0. The market value of their outstanding shares is at $2.6 billion. As per the news, the Q2 earnings report came out yesterday.
-   **Eton Pharmaceuticals** (NASDAQ:ETON) shares moved upwards by 22.79% to $50.1. The company's market cap stands at $1.1 billion. As per the press release, Q2 earnings came out yesterday.

### Losers

-   **BeyondSpring** (NASDAQ:BYSI) stock fell 19.6% to $0.8 during Friday's pre-market session. The company's market cap stands at $40.9 million.
-   **Healthcare Triangle** (NASDAQ:HCTI) stock declined by 18.5% to $1.41. The company's market cap stands at $3.5 million. As per the press release, Q2 earnings came out yesterday.
-   **Zentalis Pharmaceuticals** (NASDAQ:ZNTL) stock fell 15.67% to $3.5. The company's market cap stands at $297.4 million.
-   **Innate Pharma** (NASDAQ:IPHA) stock declined by 15.19% to $2.15. The market value of their outstanding shares is at $237.8 million.
-   **NewcelX** (NASDAQ:NCEL) stock fell 14.45% to $3.08. The company's market cap stands at $19.3 million.
-   **Cibus** (NASDAQ:CBUS) stock declined by 13.69% to $1.64. The company's market cap stands at $145.0 million. The company's, Q2 earnings came out yesterday. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [HCTI.US](https://longbridge.com/en/quote/HCTI.US.md)
- [BYSI.US](https://longbridge.com/en/quote/BYSI.US.md)
- [CAPR.US](https://longbridge.com/en/quote/CAPR.US.md)
- [ZNTL.US](https://longbridge.com/en/quote/ZNTL.US.md)
- [SXTC.US](https://longbridge.com/en/quote/SXTC.US.md)
- [AKAN.US](https://longbridge.com/en/quote/AKAN.US.md)
- [VALN.US](https://longbridge.com/en/quote/VALN.US.md)
- [HTFL.US](https://longbridge.com/en/quote/HTFL.US.md)
- [ETON.US](https://longbridge.com/en/quote/ETON.US.md)
- [IPHA.US](https://longbridge.com/en/quote/IPHA.US.md)
- [NCEL.US](https://longbridge.com/en/quote/NCEL.US.md)
- [CBUS.US](https://longbridge.com/en/quote/CBUS.US.md)
- [NLSPW.US](https://longbridge.com/en/quote/NLSPW.US.md)

## Related News & Research

- [Walters Group reports purchase of 4,335,000 Zentalis shares for $15.17 million](https://longbridge.com/en/news/296406214.md)
- [Capricor Therapeutics (CAPR) Could Be 89% Undervalued Following Deramiocel And Loss Concerns](https://longbridge.com/en/news/296098763.md)
- [BUZZ-Zentalis Pharma falls on $81 mln stock sale](https://longbridge.com/en/news/295923711.md)
- [CAPR Stock News: Capricor Therapeutics Sued for Securities Fraud over Alleged Misrepresentations and Corresponding 64% Stock Drop](https://longbridge.com/en/news/296212809.md)
- [Capricor shares skyrocket as FDA agrees to review new Duchenne drug data](https://longbridge.com/en/news/295920863.md)